FDA Adverse Event Injury Summary report: N

V40 COCR LFIT HEAD 40MM/+4

MDR report key: 3092446 · Received May 3, 2013

Report

Report Number
0002249697-2013-01532
Event Type
Injury
Date Received
May 3, 2013
Date of Event
April 10, 2013
Report Date
April 10, 2013
Manufacturer
STRYKER ORTHOPAEDICS-MAHWAH
Product Code
LPH
PMA / PMN Number
K061434
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MN, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

WHEN COMPLETED, THE EVALUATION SUMMARY WILL BE SUBMITTED IN A SUPPLEMENTAL REPORT. (B)(4): NOT RETURNED TO THE MANUFACTURER.

Additional Manufacturer Narrative · 1

AN EVENT REGARDING ALTR INVOLVING A V40 COCR LFIT HEAD 40MM/+4 WAS REPORTED. THE EVENT WAS NOT CONFIRMED. A MATERIAL ANALYSIS REPORT CONCLUDED, ¿THE MACHINED TAPERED SURFACE OF THE V40 LFIT HEAD EXHIBITED EVIDENCE OF SCRATCHES FROM THE EXPLANTATION PROCESS AS WELL AS MICRO-MOTION DAMAGE AND CORROSION DEBRIS INDICATIVE OF A MECHANICALLY ASSISTED CORROSION PROCESS. NO MATERIAL OR MANUFACTURING DEFECTS WERE OBSERVED ON THE V40 LFIT HEAD.¿ A DEVICE HISTORY REVIEW CONFIRMED ALL DEVICES ACCEPTED INTO FINISHED GOODS CONFORMED TO SPECIFICATION. A COMPLAINT HISTORY REVIEW CONFIRMED NO OTHER SIMILAR EVENTS FOR THE REPORTED LOT. THE EXACT CAUSE OF THE EVENT COULD NOT BE DETERMINED BECAUSE FURTHER INFORMATION IS NEEDED TO COMPLETE THE INVESTIGATION FOR DETERMINING THE ROOT CAUSE. NO FURTHER INVESTIGATION FOR THIS EVENT IS POSSIBLE AT THIS TIME.

Description of Event or Problem · 1

PATIENT HAD ADVERSE LOCAL TISSUE REACTION. DR. (B)(6), REVISED PATIENT'S LEFT HIP. A 36 C-TAPER BIOLOX HEAD AND V40 TO C-TAPER ADAPTER.

Description of Event or Problem · 1

PATIENT HAD ADVERSE LOCAL TISSUE REACTION. DR. (B)(6) REVISED PATIENT'S LEFT HIP. THE 36 C-TAPER BIOLOX HEAD AND V40 TO C-TAPER ADAPTER.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
194045 V40 COCR LFIT HEAD 40MM/+4 IMPLANT LPH STRYKER ORTHOPAEDICS-MAHWAH MHK128

Patients

Seq Age Sex Outcome Treatment
1 77 YR Required Intervention